In Brief: Ketoprofen Rx-to-OTC switches
This article was originally published in The Tan Sheet
Executive Summary
Ketoprofen Rx-to-OTC switches: FDA informed Bayer and Whitehall-Robins on July 19 that their respective Rx-to-OTC switch applications for nonsteroidal anti-inflammatory drug ketoprofen are "approvable." The letters were sent less than a week after FDA's Nonprescription Drugs and Arthritis Advisory Committees recommended approval of the switches ("The Tan Sheet" July 17, pp. 1-3)...